These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 360049)
1. Heparin and atherosclerosis. Engelberg H Monogr Atheroscler; 1978; (8):1-69. PubMed ID: 360049 [No Abstract] [Full Text] [Related]
2. Heparin and the atherosclerotic process. Engelberg H Pharmacol Rev; 1984 Jun; 36(2):91-110. PubMed ID: 6379681 [No Abstract] [Full Text] [Related]
3. Heparin and atherosclerosis. Engelberg H Adv Lipid Res; 1983; 20():219-55. PubMed ID: 6367388 [No Abstract] [Full Text] [Related]
4. Post-heparin lipolytic activity (PHLA) and development of atherosclerosis in vasectomized monkeys. Bansal N; Dhaunsi GS; Majumdar S; Chakravarti RN Indian J Exp Biol; 1986 Oct; 24(10):647-9. PubMed ID: 3583328 [No Abstract] [Full Text] [Related]
5. Drug prophylaxis in atherosclerosis. Jaques LB Artery; 1987; 14(4):209-15. PubMed ID: 2441684 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol and atherosclerosis-fact or fiction? Nash DT Geriatrics; 1981 Jan; 36(1):128-32. PubMed ID: 7450502 [No Abstract] [Full Text] [Related]
7. [Is treatment of metabolic factors a valid method in the control of arteriosclerosis and coronary disease?]. Avogaro P Clin Ter; 1984 Oct; 111(1):15-9. PubMed ID: 6238776 [No Abstract] [Full Text] [Related]
8. The influence of feeding soya-bean oil on postheparin plasma lipolytic activity. Cybulska B; Szostak WB; Bialkowska M; Swiatkowska K Mater Med Pol; 1973; 5(4):247-9. PubMed ID: 4799526 [No Abstract] [Full Text] [Related]
10. [Heparin in the pathogenesis, prevention and therapy of ischemic heart disease]. Riecanský I; Kusá O; Luknárová O; Haviar V Vnitr Lek; 1983 May; 29(5):439-45. PubMed ID: 6880060 [No Abstract] [Full Text] [Related]
11. Heparin, non-heparin glycosaminoglycans, and heparinoids: an overview of their application in atherosclerosis. Engelberg H Semin Thromb Hemost; 1991; 17 Suppl 1():5-8. PubMed ID: 1712511 [No Abstract] [Full Text] [Related]
13. Heparin for prevention of atherosclerosis. Shulman AG N Engl J Med; 1988 Oct; 319(17):1154-5. PubMed ID: 3173447 [No Abstract] [Full Text] [Related]
14. More on heparin for prevention of atherosclerosis. Goldstein MR N Engl J Med; 1989 Mar; 320(13):866-7. PubMed ID: 2927452 [No Abstract] [Full Text] [Related]
15. [Prevention of arteriosclerotic heart and vascular diseases]. Siedek H Wien Med Wochenschr; 1971 Jul; 121(30):575-81. PubMed ID: 5564652 [No Abstract] [Full Text] [Related]
16. Heparin and atherosclerosis: an investigative report on the treatment of atherosclerosis. Shulman AG Biomed Pharmacother; 1990; 44(6):303-6. PubMed ID: 2224062 [TBL] [Abstract][Full Text] [Related]
17. [Oral heparin in prophylaxis of atherosclerosis]. SALVINI L; SCARDIGLI G; ARADAS A Prog Med (Paris); 1956 Feb; 84(4):85-6. PubMed ID: 13310613 [No Abstract] [Full Text] [Related]
19. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Rosenberg RD Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697 [TBL] [Abstract][Full Text] [Related]
20. [The effect of heparin on blood coagulation and serotonin concentration in patients with coronary atherosclerosis in the pre-infarction state]. Savel'ev AI Vrach Delo; 1972 Nov; 11():14-8. PubMed ID: 4659725 [No Abstract] [Full Text] [Related] [Next] [New Search]